Market Overview:
The global real-world evidence solutions market size reached US$ 1.41 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.01 Billion by 2027, exhibiting a growth rate (CAGR) of 12.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Real-world evidence (RWE) refers to clinical evidence about the use and potential benefits or risks of medical products via real-world data (RWD). It can be produced via different study designs or analyses, including randomized trials, big simple trials, pragmatic trials, and observational studies. It provides insight into real-world treatment patterns in patient groups, including dosing, compliance, adherence, off-label use, and the balance between efficacy and safety. As it can also assist researchers in discovering possible patients and developing correct inclusion criteria for clinical trials, which can help them design better pre-trial studies, there is a rise in the demand for RWE solutions around the world.
Real-World Evidence Solutions Market Trends:
The growing demand for RWE solutions to get precise and clear information about the safety and efficacy of new products represents one of the key factors driving the market. Moreover, there is a rise in the demand for these solutions to detect varied reactions, product subpopulation effects, and product value when utilized by complex and comorbid patients. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Additionally, the growing utilization of advanced analytics and technological solutions in RWE for clinical development, commercialization, speed innovation, and accelerating improvements in healthcare outcomes is positively influencing the market. Besides this, there are various initiatives undertaken by governments of several countries to promote the use of RWE solutions, which provide the efficacy of drugs and vaccines. This, coupled with a shift from volume to value-based care, is offering lucrative growth opportunities to industry investors. Apart from this, the growing adoption of digitalization and patient-centered virtual care is catalyzing the demand for RWE solutions. Furthermore, there is an increase in the prevalence of chronic diseases, such as cancer, obesity, and diabetes, across the globe. In line with this, the rising delays in drug development and the subsequent increase in development costs are bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global real-world evidence solutions market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, therapeutic area and end user.
Breakup by Component:
- Clinical Settings Data
- Claims Data
- Patient-Powered Data
- Pharmacy Data
- Others
Breakup by Therapeutic Area:
- Oncology
- Immunology
- Neurology
- Cardiovascular Disease
- Others
Breakup by End User:
- Pharmaceutical and Medical Device Companies
- Healthcare Payers
- Healthcare Providers
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetion Inc., Clinigen Limited, Flatiron Health Inc. (Roche Holding AG), ICON plc, International Business Machines Corporation, IQVIA, Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation, Parexel International Corporation, PPD Inc. (Thermo Fisher Scientific Inc.), Sas Institute Inc. and Syneos Health.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Component, Therapeutic Area, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Aetion Inc., Clinigen Limited, Flatiron Health Inc. (Roche Holding AG), ICON plc, International Business Machines Corporation, IQVIA, Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation, Parexel International Corporation, PPD Inc. (Thermo Fisher Scientific Inc.), Sas Institute Inc. and Syneos Health. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global real-world evidence solutions market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global real-world evidence solutions market?
- What are the key regional markets?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the therapeutic area?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global real-world evidence solutions market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Real-World Evidence Solutions Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Clinical Settings Data
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Claims Data
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Patient-Powered Data
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Pharmacy Data
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Therapeutic Area
7.1 Oncology
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunology
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular Disease
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Pharmaceutical and Medical Device Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Healthcare Payers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Healthcare Providers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Aetion Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Clinigen Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Flatiron Health Inc. (Roche Holding AG)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 ICON plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 International Business Machines Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 IQVIA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Optum Inc. (UnitedHealth Group Incorporated)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Oracle Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Parexel International Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 PPD Inc. (Thermo Fisher Scientific Inc.)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Sas Institute Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 SWOT Analysis
14.3.12 Syneos Health
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Real-World Evidence Solutions Market: Major Drivers and Challenges
Figure 2: Global: Real-World Evidence Solutions Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Real-World Evidence Solutions Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Real-World Evidence Solutions Market: Breakup by Component (in %), 2021
Figure 5: Global: Real-World Evidence Solutions Market: Breakup by Therapeutic Area (in %), 2021
Figure 6: Global: Real-World Evidence Solutions Market: Breakup by End User (in %), 2021
Figure 7: Global: Real-World Evidence Solutions Market: Breakup by Region (in %), 2021
Figure 8: Global: Real-World Evidence Solutions (Clinical Settings Data) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Real-World Evidence Solutions (Clinical Settings Data) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Real-World Evidence Solutions (Claims Data) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Real-World Evidence Solutions (Claims Data) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Real-World Evidence Solutions (Patient-Powered Data) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Real-World Evidence Solutions (Patient-Powered Data) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Real-World Evidence Solutions (Pharmacy Data) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Real-World Evidence Solutions (Pharmacy Data) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Real-World Evidence Solutions (Other Components) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Real-World Evidence Solutions (Other Components) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Real-World Evidence Solutions (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Real-World Evidence Solutions (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Real-World Evidence Solutions (Immunology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Real-World Evidence Solutions (Immunology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Real-World Evidence Solutions (Neurology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Real-World Evidence Solutions (Neurology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Real-World Evidence Solutions (Healthcare Payers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Real-World Evidence Solutions (Healthcare Payers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Real-World Evidence Solutions (Healthcare Providers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Real-World Evidence Solutions (Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Real-World Evidence Solutions (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Real-World Evidence Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: North America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: North America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: United States: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: United States: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Canada: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Canada: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Asia-Pacific: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Asia-Pacific: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: China: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: China: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Japan: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Japan: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: India: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: India: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: South Korea: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: South Korea: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Australia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Australia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Indonesia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Indonesia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Europe: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Germany: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Germany: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: France: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: France: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United Kingdom: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United Kingdom: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Italy: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Italy: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Spain: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Spain: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Russia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Russia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Middle East and Africa: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Middle East and Africa: Real-World Evidence Solutions Market: Breakup by Country (in %), 2021
Figure 84: Middle East and Africa: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Global: Real-World Evidence Solutions Industry: SWOT Analysis
Figure 86: Global: Real-World Evidence Solutions Industry: Value Chain Analysis
Figure 87: Global: Real-World Evidence Solutions Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Real-World Evidence Solutions Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Real-World Evidence Solutions Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 3: Global: Real-World Evidence Solutions Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
Table 4: Global: Real-World Evidence Solutions Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Real-World Evidence Solutions Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Real-World Evidence Solutions Market: Competitive Structure
Table 7: Global: Real-World Evidence Solutions Market: Key Players